Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to evaluate the safety and tolerability of neratinib in
combination with vinorelbine at the maximum tolerated dose (MTD) determined in a previous
study, or to determine a lower MTD of the two drugs, as well as to obtain preliminary
information on whether the combination of the two drugs has any effect on solid tumors in
Japanese patients.